190 related articles for article (PubMed ID: 19012390)
1. A non-cross-linking platinum-acridine agent with potent activity in non-small-cell lung cancer.
Ma Z; Choudhury JR; Wright MW; Day CS; Saluta G; Kucera GL; Bierbach U
J Med Chem; 2008 Dec; 51(23):7574-80. PubMed ID: 19012390
[TBL] [Abstract][Full Text] [Related]
2. PT-ACRAMTU, a platinum-acridine anticancer agent, lengthens and aggregates, but does not stiffen or soften DNA.
Dutta S; Snyder MJ; Rosile D; Binz KL; Roll EH; Suryadi J; Bierbach U; Guthold M
Cell Biochem Biophys; 2013; 67(3):1103-13. PubMed ID: 23636685
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, biological activity, and DNA-damage profile of platinum-threading intercalator conjugates designed to target adenine.
Guddneppanavar R; Saluta G; Kucera GL; Bierbach U
J Med Chem; 2006 Jun; 49(11):3204-14. PubMed ID: 16722638
[TBL] [Abstract][Full Text] [Related]
4. Effect of the diamine nonleaving group in platinum-acridinylthiourea conjugates on DNA damage and cytotoxicity.
Guddneppanavar R; Choudhury JR; Kheradi AR; Steen BD; Saluta G; Kucera GL; Day CS; Bierbach U
J Med Chem; 2007 May; 50(9):2259-63. PubMed ID: 17408248
[TBL] [Abstract][Full Text] [Related]
5. Replacement of a thiourea with an amidine group in a monofunctional platinum-acridine antitumor agent. Effect on DNA interactions, DNA adduct recognition and repair.
Kostrhunova H; Malina J; Pickard AJ; Stepankova J; Vojtiskova M; Kasparkova J; Muchova T; Rohlfing ML; Bierbach U; Brabec V
Mol Pharm; 2011 Oct; 8(5):1941-54. PubMed ID: 21806015
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationships in platinum-acridinylthiourea conjugates: effect of the thiourea nonleaving group on drug stability, nucleobase affinity, and in vitro cytotoxicity.
Ackley MC; Barry CG; Mounce AM; Farmer MC; Springer BE; Day CS; Wright MW; Berners-Price SJ; Hess SM; Bierbach U
J Biol Inorg Chem; 2004 Jun; 9(4):453-61. PubMed ID: 15067524
[TBL] [Abstract][Full Text] [Related]
7. pH and thermo dual stimulus-responsive liposome nanoparticles for targeted delivery of platinum-acridine hybrid agent.
Zhou Q; You C; Ling Y; Wu H; Sun B
Life Sci; 2019 Jan; 217():41-48. PubMed ID: 30476500
[TBL] [Abstract][Full Text] [Related]
8. Solution structural study of a DNA duplex containing the guanine-N7 adduct formed by a cytotoxic platinum-acridine hybrid agent.
Baruah H; Wright MW; Bierbach U
Biochemistry; 2005 Apr; 44(16):6059-70. PubMed ID: 15835895
[TBL] [Abstract][Full Text] [Related]
9. DNA metalating-intercalating hybrid agents for the treatment of chemoresistant cancers.
Suryadi J; Bierbach U
Chemistry; 2012 Oct; 18(41):12926-34. PubMed ID: 22987397
[TBL] [Abstract][Full Text] [Related]
10. Unprecedented monofunctional metalation of adenine nucleobase in guanine- and thymine-containing dinucleotide sequences by a cytotoxic platinum-acridine hybrid agent.
Barry CG; Baruah H; Bierbach U
J Am Chem Soc; 2003 Aug; 125(32):9629-37. PubMed ID: 12904029
[TBL] [Abstract][Full Text] [Related]
11. Metal-intercalator-mediated self-association and one-dimensional aggregation in the structure of the excised major DNA adduct of a platinum-acridine agent.
Baruah H; Day CS; Wright MW; Bierbach U
J Am Chem Soc; 2004 Apr; 126(14):4492-3. PubMed ID: 15070347
[TBL] [Abstract][Full Text] [Related]
12. DNA minor groove adducts formed by a platinum-acridine conjugate inhibit association of tata-binding protein with its cognate sequence.
Budiman ME; Bierbach U; Alexander RW
Biochemistry; 2005 Aug; 44(33):11262-8. PubMed ID: 16101310
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a Platinum-Acridine Anticancer Agent and Its Liposomal Formulation in an in vivo Model of Lung Adenocarcinoma.
Ding S; Hackett CL; Liu F; Hackett RG; Bierbach U
ChemMedChem; 2021 Jan; 16(2):412-419. PubMed ID: 32975041
[TBL] [Abstract][Full Text] [Related]
14. Adenine-N3 in the DNA minor groove - an emerging target for platinum containing anticancer pharmacophores.
Guddneppanavar R; Bierbach U
Anticancer Agents Med Chem; 2007 Jan; 7(1):125-38. PubMed ID: 17266509
[TBL] [Abstract][Full Text] [Related]
15. Redesigning the DNA-targeted chromophore in platinum-acridine anticancer agents: a structure-activity relationship study.
Pickard AJ; Liu F; Bartenstein TF; Haines LG; Levine KE; Kucera GL; Bierbach U
Chemistry; 2014 Dec; 20(49):16174-87. PubMed ID: 25302716
[TBL] [Abstract][Full Text] [Related]
16. Rates of intercalator-driven platination of DNA determined by a restriction enzyme cleavage inhibition assay.
Choudhury JR; Rao L; Bierbach U
J Biol Inorg Chem; 2011 Mar; 16(3):373-80. PubMed ID: 21086002
[TBL] [Abstract][Full Text] [Related]
17. The effect of geometric isomerism on the anticancer activity of the monofunctional platinum complex trans-[Pt(NH
Zhou W; Almeqdadi M; Xifaras ME; Riddell IA; Yilmaz ÖH; Lippard SJ
Chem Commun (Camb); 2018 Mar; 54(22):2788-2791. PubMed ID: 29484327
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and biological activity of a novel non-cisplatin-type platinum-acridine pharmacophore.
Martins ET; Baruah H; Kramarczyk J; Saluta G; Day CS; Kucera GL; Bierbach U
J Med Chem; 2001 Dec; 44(25):4492-6. PubMed ID: 11728195
[TBL] [Abstract][Full Text] [Related]
19. Thermally inert metal ammines as light-inducible DNA-targeted agents. Synthesis, photochemistry, and photobiology of a prototypical rhodium(III)-intercalator conjugate.
Barry CG; Turney EC; Day CS; Saluta G; Kucera GL; Bierbach U
Inorg Chem; 2002 Dec; 41(26):7159-69. PubMed ID: 12495358
[TBL] [Abstract][Full Text] [Related]
20. Glucose-Appended Platinum(II)-BODIPY Conjugates for Targeted Photodynamic Therapy in Red Light.
Ramu V; Gautam S; Garai A; Kondaiah P; Chakravarty AR
Inorg Chem; 2018 Feb; 57(4):1717-1726. PubMed ID: 29400953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
